Based on the effect of APP phosphorylation on APP–TrkA binding, the APP–TrkA interaction was investigated in the AD human brain where elevated APPpT668 levels have been reported (Lee et al., 2003; Chang et al., 2006). Here, APP is linked to Alzheimer disease.